335 related articles for article (PubMed ID: 24562907)
1. Genetic validation of aminoacyl-tRNA synthetases as drug targets in Trypanosoma brucei.
Kalidas S; Cestari I; Monnerat S; Li Q; Regmi S; Hasle N; Labaied M; Parsons M; Stuart K; Phillips MA
Eukaryot Cell; 2014 Apr; 13(4):504-16. PubMed ID: 24562907
[TBL] [Abstract][Full Text] [Related]
2. Genetic manipulation of Leishmania donovani threonyl tRNA synthetase facilitates its exploration as a potential therapeutic target.
Chadha S; Vijayan R; Gupta S; Munde M; Gourinath S; Madhubala R
PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006575. PubMed ID: 29897900
[TBL] [Abstract][Full Text] [Related]
3. Non-canonical eukaryotic glutaminyl- and glutamyl-tRNA synthetases form mitochondrial aminoacyl-tRNA in Trypanosoma brucei.
Rinehart J; Horn EK; Wei D; Soll D; Schneider A
J Biol Chem; 2004 Jan; 279(2):1161-6. PubMed ID: 14563839
[TBL] [Abstract][Full Text] [Related]
4. Aminoacyl tRNA synthetases as malarial drug targets: a comparative bioinformatics study.
Nyamai DW; Tastan Bishop Ö
Malar J; 2019 Feb; 18(1):34. PubMed ID: 30728021
[TBL] [Abstract][Full Text] [Related]
5. Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond.
Galindo-Feria AS; Notarnicola A; Lundberg IE; Horuluoglu B
Front Immunol; 2022; 13():866087. PubMed ID: 35634293
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in Mice.
Shibata S; Gillespie JR; Kelley AM; Napuli AJ; Zhang Z; Kovzun KV; Pefley RM; Lam J; Zucker FH; Van Voorhis WC; Merritt EA; Hol WG; Verlinde CL; Fan E; Buckner FS
Antimicrob Agents Chemother; 2011 May; 55(5):1982-9. PubMed ID: 21282428
[TBL] [Abstract][Full Text] [Related]
7. A multiple aminoacyl-tRNA synthetase complex that enhances tRNA-aminoacylation in African trypanosomes.
Cestari I; Kalidas S; Monnerat S; Anupama A; Phillips MA; Stuart K
Mol Cell Biol; 2013 Dec; 33(24):4872-88. PubMed ID: 24126051
[TBL] [Abstract][Full Text] [Related]
8. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery.
Chhibber-Goel J; Yogavel M; Sharma A
Protein Sci; 2021 Sep; 30(9):1793-1803. PubMed ID: 34184352
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli mutants overproducing phenylalanyl- and threonyl-tRNA synthetase.
Grüll JM; Hennecke H; Fröhler J; Thomale J; Nass G; Böck A
J Bacteriol; 1979 Jan; 137(1):480-9. PubMed ID: 368026
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Aminoacyl-tRNA Synthetases in Chromerids.
Sharaf A; Gruber A; Jiroutová K; Oborník M
Genes (Basel); 2019 Jul; 10(8):. PubMed ID: 31370303
[TBL] [Abstract][Full Text] [Related]
11. [Cloning, expression, purification and activity assay of Trypanosoma brucei phenylalanyl-tRNA synthetase in Escherichia coli].
Yao Y; Gao G; Li D
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):130-5. PubMed ID: 20353103
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of isoleucyl-tRNA synthetase as a potential treatment for human African Trypanosomiasis.
Cestari I; Stuart K
J Biol Chem; 2013 May; 288(20):14256-14263. PubMed ID: 23548908
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of three protozoan homologs of tryptophanyl-tRNA synthetase.
Merritt EA; Arakaki TL; Gillespie R; Napuli AJ; Kim JE; Buckner FS; Van Voorhis WC; Verlinde CL; Fan E; Zucker F; Hol WG
Mol Biochem Parasitol; 2011 May; 177(1):20-8. PubMed ID: 21255615
[TBL] [Abstract][Full Text] [Related]
14. Dual targeting of a single tRNA(Trp) requires two different tryptophanyl-tRNA synthetases in Trypanosoma brucei.
Charrière F; Helgadóttir S; Horn EK; Söll D; Schneider A
Proc Natl Acad Sci U S A; 2006 May; 103(18):6847-52. PubMed ID: 16636268
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting of aminoacyl-tRNA synthetases to the apicoplast and cytosol in Plasmodium falciparum.
Jackson KE; Pham JS; Kwek M; De Silva NS; Allen SM; Goodman CD; McFadden GI; Ribas de Pouplana L; Ralph SA
Int J Parasitol; 2012 Feb; 42(2):177-86. PubMed ID: 22222968
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase Inhibitors.
Zhang Z; Koh CY; Ranade RM; Shibata S; Gillespie JR; Hulverson MA; Huang W; Nguyen J; Pendem N; Gelb MH; Verlinde CL; Hol WG; Buckner FS; Fan E
ACS Infect Dis; 2016 Jun; 2(6):399-404. PubMed ID: 27627628
[TBL] [Abstract][Full Text] [Related]
17. Deoxyhypusine Modification of Eukaryotic Translation Initiation Factor 5A (eIF5A) Is Essential for Trypanosoma brucei Growth and for Expression of Polyprolyl-containing Proteins.
Nguyen S; Leija C; Kinch L; Regmi S; Li Q; Grishin NV; Phillips MA
J Biol Chem; 2015 Aug; 290(32):19987-98. PubMed ID: 26082486
[TBL] [Abstract][Full Text] [Related]
18. Role of aminoacyl-tRNA synthetases in infectious diseases and targets for therapeutic development.
Dewan V; Reader J; Forsyth KM
Top Curr Chem; 2014; 344():293-329. PubMed ID: 23666077
[TBL] [Abstract][Full Text] [Related]
19. Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogens.
Kelly P; Hadi-Nezhad F; Liu DY; Lawrence TJ; Linington RG; Ibba M; Ardell DH
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007983. PubMed ID: 32106219
[TBL] [Abstract][Full Text] [Related]
20. Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening.
Pedró-Rosa L; Buckner FS; Ranade RM; Eberhart C; Madoux F; Gillespie JR; Koh CY; Brown S; Lohse J; Verlinde CL; Fan E; Bannister T; Scampavia L; Hol WG; Spicer T; Hodder P
J Biomol Screen; 2015 Jan; 20(1):122-30. PubMed ID: 25163684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
